Companies

Black Diamond Therapeutics, Inc. (BDTX) SEC filings

CIK 0001701541 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)
Net income (USD)-82.4 M-91.2 M-125.6 M
Diluted EPS (USD/shares)0.39-1.88-2.52

Latest filings

FiledFormDescriptionPeriod
2026-09-21442026-09-18
2026-09-21442026-09-18
2026-08-0510-Q10-Q2026-06-30
2026-08-058-K8-K items 2.02,9.012026-08-05
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-29442026-06-26
2026-06-29442026-06-26
2026-06-29442026-06-26
2026-06-29442026-06-26
2026-06-29442026-06-26
2026-06-29442026-06-26
2026-06-298-KFORM 8-K items 5.072026-06-26
2026-06-22442026-06-19
2026-06-22442026-06-19
2026-05-218-KFORM 8-K items 7.01,8.01,9.012026-05-21
2026-05-0710-Q10-Q2026-03-31
2026-05-078-K8-K items 2.02,9.012026-05-07
2026-04-29ARSARS2025-12-31
2026-04-29DEFA14ADEFA14A
2026-04-29DEF 14ADEF 14A2026-06-26
2026-03-20442026-03-20
2026-03-20442026-03-20
2026-03-16S-8FORM S-8
2026-03-1610-K10-K2025-12-31

Forms on file (last 1,000): 4 247, 8-K 61, 3 35, 10-Q 20, 144 17, SC 13G 10, SC 13G/A 8, SC 13D/A 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=BDTX (0.002 USD), /gw/filings/filings?ticker=BDTX&form=8-K, /gw/filings/facts?ticker=BDTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange